| Trial ID: | L0434 |
| Source ID: | NCT01709994
|
| Associated Drug: |
Aspirin
|
| Title: |
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease Stage 4|Chronic Kidney Disease Stage 3
|
| Interventions: |
DRUG: Aspirin
|
| Outcome Measures: |
Primary: Cardiovascular events, To assess the benefit of treatment with low-dose aspirin in the primary prevention of cardiovascular events (incidence of the composite endpoint: death, acute coronary syndrome, stroke or nonfatal acute peripheral arteriopathy disease) in patients with chronic kidney disease who are not in dialysis or renal transplant., five years | Secondary: Major bleeding, -Evaluate the incidence of major bleeding requiring hospitalization, five years|antiinflammatory effects of aspirin, -to analyze the antiinflammatory effect of aspirin in patients with chronic kidney disease, five years | Other: progression of chronic kidney disease, to Analyze the progression of CKD, five years
|
| Sponsor/Collaborators: |
Sponsor: Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
97
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2010-05
|
| Completion Date: |
2015-05
|
| Results First Posted: |
|
| Last Update Posted: |
2012-10-18
|
| Locations: |
Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT01709994
|
